Deep Genomics
General contacts
Investor type
PE / VC
Founded
2014
AUM
$236 M
Location
Toronto, Ontario, Canada
$10-50 m
Investment Ticket
3-5 years
Investment Horizon
Seed,
Series A,
Series B,
Late Stage (Series C+)
Investment Stage
Sale to strategic investor,
IPO,
M&A,
Sale,
Buyout,
Mergers and Aquisitions,
Pre-agreed exit,
Add-on acquistions
Exit Strategy
Investor profile last updated: 27 July, 2026
Profile
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Industry
Region of investment
Deep Genomics Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Deep Genomics funding rounds
|
Venture Capital (VC)
|
Consumer Services (B2C)
Healthcare Services
AI
Technology
HealthTech
Machine Learning (ML)
|
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$236 M
|
November 2014
|
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about Deep Genomics
Where is Deep Genomics located?
Deep Genomics is located in Toronto, Ontario, Canada.
When was Deep Genomics founded?
Deep Genomics was founded in 2014.
What sectors and industries does Deep Genomics invest in?
Deep Genomics invests in companies and startups in Healthcare Services, AI, Technology, HealthTech, Machine Learning (ML), Consumer Services (B2C).
What is Deep Genomics geographical focus of investments?
Deep Genomics invests in companies and startups in North America, Europe.
At what stages of companies and startups does Deep Genomics typically invest in?
Deep Genomics invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).
What is the usual amount of Deep Genomics investment?
Deep Genomics usually invests $10-50 m on average.
What is the amount of assets of under management (AUM) for Deep Genomics?
Deep Genomics has around $236m assets under management.
When was Deep Genomics last fund created?
Deep Genomics last fund was created/launched in 2014-11-10